The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies.
Sakellari I et al. Clin Lymphoma Myeloma Leuk. 2017 Jun 29. pii: S2152-2650(17)30096-4. doi: 10.1016/j.clml.2017.06.008. [Epub ahead of print].

Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Multiple Myeloma.
Ghosh N et al. Biol Blood Marrow Transplant. 2017 Jul 12. pii: S1083-8791(17)30572-4. doi: 10.1016/j.bbmt.2017.07.003. [Epub ahead of print].

The need for endodontic treatment and systemic characteristics of hematopoietic stem cell transplantation patients.
Braga-Diniz JM et al. Braz Oral Res. 2017 Jul 3;31:e50. doi: 10.1590/1807-3107BOR-2017.vol31.0050.